References
- DulcanMPractice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent PsychiatryJ Am Acad Child Adolesc Psychiatry199736Suppl 1085S121S9334567
- FaraoneSVSergeantJGillbergCBiedermanJThe worldwide prevalence of ADHD: is it an American condition?World Psychiatry200322104113
- National Board of Health and WelfareKraftig ökning av adhd-läkemedel till vuxna [Substantial increase in the prescription of ADHD drugs for adults]2012 Available from: http://www.socialstyrelsen.se/nyheter/2012oktober/kraftigokningavadhd-lakemedeltillvuxnaAccessed March 10, 2017
- FayyadJDe GraafRKesslerRCross-national prevalence and correlates of adult attention-deficit hyperactivity disorderBr J Psychiatry200719040240917470954
- KesslerRCAdlerLAmesMThe prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workersJ Occup Environ Med200547656557215951716
- KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationAm J Psychiatry2006163471672316585449
- KooijJJBuitelaarJKvan den OordEJFurerJWRijndersCAHodiamontPPInternal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adultsPsychol Med200535681782715997602
- SimonVCzoborPBalintSMeszarosABitterIPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysisBr J Psychiatry2009194320421119252145
- NylanderLHolmqvistMGustafsonLGillbergCAttention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in adult psychiatry. A 20-year register studyNord J Psychiatry201367534435023234539
- BiedermanJWilensTSpencerTDiagnosis and treatment of adults with attention-deficit/hyperactivity disorderCNS Spectr2007126115
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)Arlington, VA, USAAmerican Psychiatric Publishing2013
- American Psychiatric AssociationAttention-deficit and disruptive behavior disorders. Attention-deficit/hyperactivity disorderDiagnostic and Statistical Manual of Mental DisordersFourth editionArlington, VA, USAAmerican Psychiatric Association200085103
- World Health OrganizationInternational Classification of Diseases (ICD-10)Geneva, SwitzerlandWHO1992
- CorbisieroSStieglitzRDRetzWRoslerMIs emotional dysregulation part of the psychopathology of ADHD in adults?Atten Defic Hyperact Disord201352839223208078
- TrottGEAttention-deficit/hyperactivity disorder (ADHD) in the course of lifeEur Arch Psychiatry Clin Neurosci2006256Suppl 1I21I2516977547
- National Board of Health and WelfareStöd till barn, ungdomar och vuxna med adhd – ett kunskapsstöd [Support for children, adolescents and adults with ADHD – a knowledge support]2014 Available from: http://www.socialstyrelsen.se/publikationer2014/2014-10-42Accessed March 15, 2017
- Medical Products AgencyUppdaterad rekommendation för läkemedels-behandling av adhd [Updated recommendations for pharmacological treatment of ADHD]2016 Available from: https://lakemedelsverket.se/Alla-nyheter/NYHETER-2016/Uppdaterad-rekommendation-for-lakemedelsbehandling-av-adhd/Accessed March 10, 2017
- AbleSLHaynesVHongJDiagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in EuropePragmat Obs Res20145213327774026
- ChangZLichtensteinPD’OnofrioBMSjolanderALarssonHSerious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based studyJAMA Psychiatry201471331932524477798
- ChangZLichtensteinPHalldnerLStimulant ADHD medication and risk for substance abuseJ Child Psychol Psychiatry201455887888525158998
- LichtensteinPHalldnerLZetterqvistJMedication for attention deficit-hyperactivity disorder and criminalityN Engl J Med2012367212006201423171097
- BahmanyarSSundstromAKaijserMvon KnorringALKielerHPharmacological treatment and demographic characteristics of pediatric patients with Attention Deficit Hyperactivity Disorder, SwedenEur Neuropsychopharmacol201323121732173823953271
- KooijSJBejerotSBlackwellAEuropean consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHDBMC Psychiatry2010106720815868
- SobanskiEPsychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD)Eur Arch Psychiatry Clin Neurosci2006256Suppl 1i26i3116977548
- PottegardABjerregaardBKGlintborgDKortegaardLSHallasJMorenoSIThe use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspectiveEur J Clin Pharmacol201369358959822811260
- FASSElvanse Summary of Product Characteristics2015 Available from: http://www.fass.se/LIF/product?8&userType=2&nplId=20140130000137&docType=6Accessed March 10, 2017
- PottegardABjerregaardBKGlintborgDHallasJMorenoSIThe use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspectiveEur J Clin Pharmacol201268101443145022434389
- ZetterqvistJAshersonPHalldnerLLangstromNLarssonHStimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009Acta Psychiatr Scand20131281707722943458
- National Board of Health and WelfareSweden National Patient Register 20112011 Available from: http://ghdx.healthdata.org/record/sweden-national-patient-register-2011Accessed March 10, 2017
- WettermarkBHammarNForedCMThe new Swedish prescribed drug register-opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiol Drug Saf200716772673516897791
- World Health OrganizationWHO Guidelines for ATC classification and DDD assignment2015 Available from: http://www.whocc.noAccessed March 10, 2017
- OlssonJAhlqvist RastadJLäkemedelsbehandling av ADHD–Bakgrundsdokumentation: Förskrivningsmönster ADHD-läkemedel i Sverige Information frå Läkemedelsverket 1:2009 [Pharmacological treatment of ADHD-background documentation: prescription pattern of ADHD medication in Sweden. Information from the medical products agency]2009 Available from: https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/bakg_dok/ADHD-bakgrund_webb_bokm%C3%A4rken.pdfAccessed March 10, 2017
- Statistic SwedenStatistical database2013 Available from: http://www.statistikdatabasen.scb.se/pxweb/en/ssd/START__BE__BE0101__BE0101A/FolkmangdNov/?rxid=bf7d1575-c52e-49d4-a01f-32d806668c10Accessed March 10, 2017
- Mohr JensenCSteinhausenHCTime trends in incidence rates of diagnosed attention-deficit/hyperactivity disorder across 16 years in a nationwide Danish registry studyJ Clin Psychiatry2015763e334e34125830455
- KnightTKKawatkarAHodgkinsPPrevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care populationCurr Med Res Opin20143071291129924597796
- PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
- ZoegaHFuruKHalldorssonMThomsenPHSouranderAMartikainenJEUse of ADHD drugs in the Nordic countries: a population-based comparison studyActa Psychiatr Scand2011123536036720860726
- WilensTEAdlerLAAdamsJMisuse and diversion of stimulants prescribed for ADHD: a systematic review of the literatureJ Am Acad Child Adolesc Psychiatry2008471213118174822
- MarianiJJLevinFRTreatment strategies for co-occurring ADHD and substance use disordersAm J Addict200716Suppl 1455417453606